HRT FINANCIAL LP sold $32K of SHPH
HRT FINANCIAL LP sold 9,022 shares of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) at $3.51 on 2026-07-06.
How this was made
The 30-second read
Why it matters
The newest concrete fact is the reported sale of 9,022 shares at $3.51 on 2026-07-06, with holdings after the transaction of 81,385 shares; no company performance or guidance changes are disclosed.
Market read
Traders may monitor for continued insider selling, but the filing alone does not provide a new fundamental catalyst.
What to watch
The article lacks context on total holdings over time, whether other insiders sold, and whether the sale was part of broader planned diversification.
Background
This is an SEC Form 4 insider transaction filed by HRT Financial LP, identified as a 10% owner of Shuttle Pharmaceuticals Holdings, Inc.
Ticker impact
HRT Financial LP, a 10% owner of Shuttle Pharmaceuticals, sold 9,022 shares in an open-market transaction at $3.51 on 2026-07-06.
Likely limited near-term impact; any effect would be sentiment-driven and small unless follow-on filings show sustained selling.
The filing is a Form 4 insider transaction with a small-to-moderate dollar value and no 10b5-1 plan stated; however, insider sales are often non-informational and the article provides no additional company-specific catalyst.
Market effects
No clear sector read-through; this is a single-company insider sale disclosure.
None indicated.
None indicated.
Counterpoint
Because the sale is open-market and not clearly linked to a 10b5-1 plan, it could be interpreted as liquidity/portfolio management rather than bearish information.
Key entities
- issuerShuttle Pharmaceuticals Holdings, Inc.
Subject of the Form 4 insider transaction; 10% owner HRT Financial LP sold shares.
- insiderHRT Financial LP
10% owner who executed the open-market sale reported in the Form 4.